Christopher C. Woller

Davis Polk advised Kontoor Brands, Inc. and Lee Wrangler International SAGL, Kontoor’s wholly owned Swiss subsidiary, in connection with a $750 million senior secured term loan A facility,…

Davis Polk advised the joint book-running managers and initial purchasers in a Rule 144A/Regulation S offering of €195 million principal amount of senior secured notes due 2026 of WMG…

Davis Polk is advising The Ferrero Group on its $1.3 billion acquisition of Kellogg Company’s cookie, fruit and fruit-flavored snack, ice cream cone and pie crust businesses. The…

Davis Polk advised the sole book-runner in connection with the SEC-registered secondary offering of 10,835,145 shares of common stock of NeoGenomics, Inc. by the selling stockholder, GE…

Davis Polk is advising Novo Nordisk on its $145 million acquisition of the U.S. and Canadian rights to Macrilen from Strongbridge Biopharma Plc. Novo Nordisk will also acquire newly issued…

Davis Polk advised the joint book-running managers and the initial purchasers in a Rule 144A/Regulation S offering of €250 million principal amount of senior secured notes due 2026 of WMG…

Davis Polk is advising Emerson on its acquisition of Intelligent Platforms, a division of General Electric. The acquisition is expected to close in the first half of Emerson’s 2019 fiscal…

Davis Polk is advising SS&C Technologies Holdings, Inc. on its $1.5 billion acquisition of Intralinks Holdings, Inc. from affiliates of Siris Capital Group. The transaction is expected…

Davis Polk advised the joint book-running managers and representatives of the several underwriters in connection with the approximately $125 million public offering of common stock of…

Davis Polk advised the representatives of the several underwriters in connection with the $60 million initial public offering of common stock of Constellation Pharmaceuticals, Inc. The…